Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

CHLOROBUTANOL CRS (50 MG)

CHLOROBUTANOL CRS (50 MG)

ND

DISCOVER
MARRUBIIN CRS (15 MG)

MARRUBIIN CRS (15 MG)

ND

DISCOVER
BENZATHINE PHENOXYMETHYLPENICILLIN FOR SYSTEM SUITABILITY CR

BENZATHINE PHENOXYMETHYLPENICILLIN FOR SYSTEM SUITABILITY CR

ND

DISCOVER
CALCIFEDIOL FOR IMPURITY D IDENTIFICATION CRS (5 MG)

CALCIFEDIOL FOR IMPURITY D IDENTIFICATION CRS (5 MG)

ND

DISCOVER
CALCIPOTRIOL FOR SYSTEM SUITABILITY CRS (5 MG)

CALCIPOTRIOL FOR SYSTEM SUITABILITY CRS (5 MG)

ND

DISCOVER
ETANERCEPT BRP (50 MG)

ETANERCEPT BRP (50 MG)

ND

DISCOVER
AMMONIO METHACRYLATE COPOLYMER CRS (25 MG)

AMMONIO METHACRYLATE COPOLYMER CRS (25 MG)

ND

DISCOVER
GRISEOFULVIN FOR SYSTEM SUITABILITY CRS (10 MG)

GRISEOFULVIN FOR SYSTEM SUITABILITY CRS (10 MG)

ND

DISCOVER
TYPHANEOSIDE CRS (20 MG)

TYPHANEOSIDE CRS (20 MG)

ND

DISCOVER
GRISEOFULVIN FOR LC ASSAY ANDIDENTIFICATION CRS (110 MG)

GRISEOFULVIN FOR LC ASSAY ANDIDENTIFICATION CRS (110 MG)

ND

DISCOVER
INFLIXIMAB CRS (100 MG)

INFLIXIMAB CRS (100 MG)

ND

DISCOVER
EVEROLIMUS CRS (70 MG)

EVEROLIMUS CRS (70 MG)

159351-69-6

DISCOVER